Title: A real-world study of chemotherapy treatment and costs in metastatic urothelial cancer (mUC) patients in the United States.

e16009Background: Cisplatin (CIS)-based regimens are recommended for first-line (1L) treatment of mUC. Carboplatin (CAR) serves as an alternative for patients unfit to receive CIS. This study exami...